New product: Fintepla (fenfluramine) 2.2 mg/mL oral solution

Fenfluramine is a serotonin releasing agent licensed for the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

electronic Medicines compendium